CureMetrix vs Exo

cmTriage (K183285, March 2019) scores screening mammograms so high-suspicion cases are read first, and a second clearance from July 2026 adds breast arterial calcification quantification. Trade press reported validation on Hologic and then GE platforms. Breast imaging centers buy CureMetrix for the screening read.

Exo Imaging sells a handheld ultrasound with AI for cardiac, lung and fluid assessment. An August 2026 release describes a subscription-free option with a one-time activation, and price comes through the Exo Store or sales. openFDA lists eight Exo records, among them Lung AI (K243239, April 2025) and Strain AI (K242359, November 2024). Fort Bend County EMS and Geisinger appear in the vendor's case studies, so the purchase sits with point-of-care clinicians scanning at the bedside. A breast center that reads mammograms and an emergency team that scans patients with a probe each buy from their own vendor.